Fluoxetine capsules are indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder., Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)., Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa., Acute treatment of Panic Disorder, with or without agoraphobia.
From the U.S. FDA-approved label for Fluoxetine. Full label: DailyMed.
Fluoxetine capsules are indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder., Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)., Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa., Acute treatment of Panic Disorder, with or without agoraphobia. Fluoxetine capsules and Olanzapine in Combination is indicated for the treatment of: Acute treatment of depressive episodes associated with Bipolar I Disorder., Treatment Resistant Depression (Major Depressive Disorder in patient, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode). When using fluoxetine capsules and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax ®.
From the U.S. FDA-approved label for Fluoxetine. Full label: DailyMed.
Consider a dose increase after several weeks if insufficient clinical improvement is observed. Administer doses above 20 mg/day once daily in the morning or twice daily (i.e., morning and noon). In controlled trials used to support the efficacy of fluoxetine, patients were administered morning doses ranging from 20 to 80 mg/day.
Directions from the U.S. FDA-approved label for Fluoxetine — your doctor or pharmacist may advise differently.
When using fluoxetine and olanzapine in combination, also refer to the Contraindications section of the package insert for Symbyax., Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine. Do not use fluoxetine capsules within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start fluoxetine in a patient who is being treated with linezolid or intravenous methylene blue, Pimozide: Do not use.
Excerpt from the U.S. FDA-approved label for Fluoxetine. Talk to a pharmacist or doctor before use.
When using fluoxetine and olanzapine in combination, also refer to the Warnings and Precautions section of the package insert for Symbyax., Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults: Monitor for clinical worsening and suicidal thinking and behavior, Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including fluoxetine, both when taken alone, but especially when co-administered with other serotonergic agents. If such symptoms occur, discontinue fluoxetine and serotonergic agents and initiate supportive treatment.
Warnings and precautions excerpt from the U.S. FDA-approved label for Fluoxetine — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in more detail in other sections of the labeling: Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Allergic Reactions and Rash, Screening Patients for Bipolar Disorder and Monitoring for Mania/Hypomania, Seizures, Altered Appetite and Weight, Increased Risk of Bleeding, Angle-Closure Glaucoma, Hyponatremia, Anxiety and Insomnia, QT…
Excerpt from the U.S. FDA-approved label for Fluoxetine — not a complete list. Talk to a pharmacist or doctor about side effects.
25 brands · 15 makers in the NepalDoc catalog — see the full Fluoxetine guide →
Protect from light and preserve in tight containers. Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Fluoxetine.
What is Flunil 20?
Flunil 20mg Capsule is a Fluoxetine medicine made by Intas Pharmaceuticals Ltd. It comes as 20mg Capsule.
What is the generic name of Flunil 20?
The generic name of Flunil 20 is Fluoxetine.
Which brands of Fluoxetine are available in Nepal?
25 brands of Fluoxetine are listed in the NepalDoc catalog, from 15 makers — including Deplox 20mg Capsule, Exidep 20mg Tablet, Faxtin-10mg Tablet, Faxtin-20mg Tablet, Fextin 10mg Capsule, Ffludac 60 mg Capsule.
What are the side effects of Fluoxetine?
The following adverse reactions are discussed in more detail in other sections of the labeling: Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Allergic Reactions and Rash, Screening Patients for Bipolar Disorder and Monitoring for Mania/Hypomania, Seizures, Altered Appetite and Weight, Increased Risk of Bleeding, Angle-Closure Glaucoma, Hyponatremia, Anxiety and Insomnia, QT…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
